Boston Scientific Corp. (NYSE:BSX) is warning physicians that some models of its implantable cardiac defibrillators have shown a higher rate of magnetic reed-switch failure, according to the Wall Street Journal.
The Natick, Mass.-based medical device maker said the ICDs, manufactured between January 2006 and November 2007, aren’t distributed today. No patient deaths or injuries beyond device replacement have been reported, according to the Journal, which noted that Boston Scientific attributed a rate of one failure per 670 devices to the problem. The probability of harm is estimated to be less than one in one million.